{"id":"W4317103607","doi":"10.1136/ard-2022-223595","title":"Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Toronto; University Health Network","funders":"UCB Pharma","keywords":"Medicine; Internal medicine; Placebo; Ankylosing spondylitis; Adverse effect; Axial spondyloarthritis; Clinical endpoint; Upper respiratory tract infection; Physical therapy; Clinical trial; Sacroiliitis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01080326,0.002248078,0.00615756,0.0006217545,0.0009806242,0.001936746,0.001477027,0.003866681,0.005672842],"category_scores_gemma":[0.01074649,0.001125399,0.005206285,0.0009740007,0.001716912,0.001872038,0.0006791198,0.003409383,0.001007956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001166581,"about_ca_system_score_gemma":0.002167748,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008835517,"about_ca_topic_score_gemma":0.001570975,"domain_scores_codex":[0.9940515,0.003689485,0.0006457149,0.0006954725,0.0005178259,0.0003999829],"domain_scores_gemma":[0.9940362,0.002302868,0.001634182,0.0005667502,0.0005938154,0.0008662206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9803601,0.003579521,0.0003487697,0.001209646,0.001760067,0.00002624969,0.00007557218,0.0001681174,0.00134184,0.00005620174,0.0004341292,0.01063974],"study_design_scores_gemma":[0.9649575,0.03222155,0.00117724,0.00007563679,0.0006938743,0.00002727706,0.00001660308,0.0001198946,0.0001690929,0.00009133767,0.0004354641,0.00001456554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9263698,0.04228544,0.002509041,0.001723935,0.001572653,0.0190947,0.002928518,0.0002594668,0.003256489],"genre_scores_gemma":[0.9356636,0.01805531,0.005319351,0.002648716,0.00144719,0.03088974,0.002682005,0.00008621232,0.003207874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01080326,"threshold_uncertainty_score":0.05713379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06558204747201496,"score_gpt":0.377787311812416,"score_spread":0.312205264340401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}